DEBBIA, EUGENIO
 Distribuzione geografica
Continente #
EU - Europa 32.002
AS - Asia 3.092
NA - Nord America 1.417
SA - Sud America 225
AF - Africa 66
OC - Oceania 2
Totale 36.804
Nazione #
IT - Italia 31.432
SG - Singapore 1.489
US - Stati Uniti d'America 1.332
CN - Cina 821
VN - Vietnam 438
FR - Francia 312
BR - Brasile 146
HK - Hong Kong 110
FI - Finlandia 95
DE - Germania 47
BD - Bangladesh 43
AR - Argentina 35
MX - Messico 35
JP - Giappone 33
CH - Svizzera 28
CA - Canada 26
IN - India 26
IQ - Iraq 23
GB - Regno Unito 20
ID - Indonesia 15
NL - Olanda 15
ZA - Sudafrica 14
PH - Filippine 13
RU - Federazione Russa 13
TH - Thailandia 10
VE - Venezuela 10
CO - Colombia 9
MA - Marocco 9
EG - Egitto 8
ES - Italia 8
PY - Paraguay 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
EC - Ecuador 7
KE - Kenya 7
KR - Corea 7
DZ - Algeria 6
IE - Irlanda 6
CL - Cile 5
JM - Giamaica 5
JO - Giordania 5
MY - Malesia 5
PK - Pakistan 5
AZ - Azerbaigian 4
KZ - Kazakistan 4
UA - Ucraina 4
AO - Angola 3
BG - Bulgaria 3
ET - Etiopia 3
PE - Perù 3
PL - Polonia 3
PR - Porto Rico 3
RE - Reunion 3
TN - Tunisia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AG - Antigua e Barbuda 2
BB - Barbados 2
CG - Congo 2
CR - Costa Rica 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
LV - Lettonia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TR - Turchia 2
UY - Uruguay 2
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
ME - Montenegro 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 36.797
Città #
Genova 19.650
Genoa 6.382
Rapallo 3.377
Vado Ligure 1.746
Singapore 708
San Jose 581
Lauterbourg 300
Ho Chi Minh City 130
New York 115
Ashburn 112
Hong Kong 102
Hanoi 101
Helsinki 94
Beijing 86
Bordighera 70
Santa Clara 59
Frankfurt am Main 39
Tokyo 29
Zurich 28
Mexico City 22
Da Nang 20
Rome 19
Los Angeles 16
São Paulo 16
Chicago 15
Tianjin 15
Haiphong 14
Milan 12
Amsterdam 11
Hải Dương 11
Biên Hòa 10
Buffalo 10
Florence 10
Baghdad 9
Dallas 9
Orem 9
Shenzhen 9
Naples 8
City of London 7
Dhaka 7
Las Vegas 7
Mumbai 7
Atlanta 6
Cardiff 6
Dublin 6
Guangzhou 6
Houston 6
Ninh Bình 6
Shanghai 6
Turin 6
Cairo 5
Curitiba 5
London 5
Montreal 5
Nairobi 5
Padua 5
Palermo 5
Rio de Janeiro 5
San Francisco 5
The Bronx 5
Washington 5
Amman 4
Asunción 4
Bangkok 4
Bologna 4
Can Tho 4
Casablanca 4
Chennai 4
Cossato 4
Council Bluffs 4
Denver 4
Des Moines 4
Johannesburg 4
Kingston 4
Moscow 4
Nuremberg 4
Phoenix 4
Quito 4
Quảng Ngãi 4
Quận Bình Thạnh 4
Seattle 4
Tashkent 4
Teverola 4
Toronto 4
Astana 3
Baku 3
Blumenau 3
Brooklyn 3
Buenos Aires 3
Cagliari 3
Caracas 3
Colombo 3
Columbus 3
Delhi 3
Diadema 3
Franca 3
Jinan 3
Kansas City 3
Karachi 3
Long Xuyen 3
Totale 34.225
Nome #
Confronto tra gli effeti dei mucolitici N-acetilcisteina, ambroxol, bromexina e sobrerolo sulla sintesi e sulla degradazione di biofilm di Staphylococcus aureus. 1.779
L'azitromicina induce l'eliminazione di diversi plasmodi in Klebsiella pneumoniae- 369
. In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance 197
Epidemiological study of pathogens isolated from blood in Liguria during 2011. 194
Antibiotic susceptibility patterns and serotypes of antibiotic resistant and or invasive Streptococcus pneumoniae strains circulating in Italy 188
Synergistic antibacterial interaction of cefotaxime and desacetylcefotaxime. 177
Activity of Bay 12-8039 against well-characterised antibiotic resistant S.pyogenes. 175
Antistaphylococcal activity of cefdinir, a new oral third-generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels. 175
Emergence of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains and spread of an isolate of sequence type 258 in the neuro-rehabilitation unit of an Italian hospital. 169
Antibacterial profile of flurithromycin, a new macrolide 165
Antibiotic resistance of clinical isolates of Enterococcus in Italy. 164
In vitro antimicrobial activity of tigecycline against Gram-negative and Gram-positive pathogens collected in Northen Italy (T.E.S.T. program 2010). 164
Adesione batterica e fungina a materiali protesici del cavo orale. 163
Mannose-inhibitable adhesins and T3-T7 receptors of Klebsiella pneumoniae inhibit phagocytosis and intracellular killing by human polymorphonuclear leukocytes. 160
Antibacterial activity of ceftibuten, a new oral third generation cephalosporin. 160
Alpha-(1 H-imidazol-1-ylmethylene) ketones with antimycotic activity 159
Epidemiology of multi-resistance Gram negative pathogen circulating in Liguria and molecular characterization of different carbapenemases. 159
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. 158
Does the adoption of EUCAST susceptibility breackpoints affects the selection of antimicrobials to treat acute community-acquired respiratory tract infections? 158
Characterization of Fluoroquinolone-Resistant Escherichia coli Causing Septicemic Colibacillosis in Calves in Italy: Emergence of a Multiresistant O78 Clonal Group. 157
Antibacterial resistance in Streptococcus pneumoniae and Haemophilus influenzae from Italy and Spain: data from the PROTEKT surveillance study, 1999-2000. 157
The Susceptibility of Candida albicans to Gamma-Radiations and Ketoco-nazole Depends on Transitional Filamentation. 157
Antibacterial activity in vitro of tigemonam, new oral monobactam. 156
Alteration of Membrane Permeability of Bacteria and Yeast by High Frequency Alternating Current (HFAC). 155
Antibiotic persistence: the role of spontaneous DNA repair response 154
Post antibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA 153
A new in vitro model system to study antimycotic drugs. 150
In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy 149
Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy 146
Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy. 146
Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults 146
Antibiotic resistance among S.pneumoniae isolated in Italy. 145
Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey. 145
Interazione sinergica di teicoplanina e vancomicina con ceftazidime e azitromicina nei confronti di Pseudomonas aeruginosa. 144
Epidemiological study of pathogens isolated from blood in Liguria (January-April 2010). 144
Enhanced biofilm-production in pathogens isolated from patients with rare metabolic disorders 142
Antibiotic susceptibility patterns and serotypes of nasopharyngeal Streptococcus pneumoniae circulating in healthy italian children. 141
Detection of macrolide resistance genes in Streptococcus pneumoniae using a rapid method 140
Antibiotic susceptibility tests directly on urine samples using Uro-Quick, a rapid automated system 140
F'lac integrative suppression in gyrB(Ts) mutan 139
Evaluation of the uro-Quick system for antibiotic susceptibility tests of strains collected from intensive care units 139
In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy 138
Adesione alla chitina di vibrioni isolati nel Mar Ligure 138
Antibiotic persistence: the role of spontaneous DNA repair. 134
Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations 134
In vitro interaction between ceftazidime and vancomycin/teicoplanin in the presence of azithromycin against Pseudomonas aeruginosa. 134
Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. 133
Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004). 133
European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. 133
In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci. 132
Pleiotropic effect of sodium arsenite on Escherichia coli 131
Indagine sulla diffusione di stafilococchi resistenti alla meticillina in Liguria 131
Evaluation of induced and spontaneous contamination of ocular medications after first opening. 131
Microbial epidemiology patterns of surgical infection pathogens. 130
Antimicrobial effect of MTAD, Tetraclean, Cloreximid, and sodium hypochlorite on three common endodontic pathogens 130
Antibacterial activity of cefetamet against respiratory pathogens. 129
Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial. 129
Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. 128
Antibiotic resistance- An unsolved problem [Antibiotico resistenza. Un problema tuttora aperto] 128
In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria. 127
Attività antistafilococcica del cefdinir, una nuova cefalosporina orale, in condizione di supera- e sub-MIC. 127
Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project 127
Identificazione di resistenze agli antibiotici ben caratterizzate mediante sistema Uro-Quick. 126
Evoluzione di Streptococcus agalactiae verso la resistenza alla penicillina 126
Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens. 125
Evolution of antibiotic resistance in Gram-positive pathogens 125
Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital 125
Evaluation of the post-antibiotic effect induced by various antibiotics against staphylococci and enterococci. 124
Antistaphylococcal activity of cefdinir alone and in combination with other drugs. 124
Identificazione della resistenza alla vancomicina negli Enterococchi con sistema Uro-Quick 123
Clinical microbiology of oral cephalosporins 123
In vitro activity of ceftibuten at sub-inhibitory concentrations in comparison with other antibiotics against respiratory and urinary tract pathogens 123
Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and ten other antibiotics. 123
In vitro effects of vancomycin and rifampicin, alone and in combination, against methicillin-sensitive and methicil­lin resistant staphylococci. 123
Comparative activity of linezolid against staphylococci and enterococci isolated in Italy 122
Filamentation promotes F'lac loss in Escherichia coli K12. 122
In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics. 122
Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak 121
In vitro assessment of the postantibiotic effect of lomefloxacin against gram-positive and gram-negative pathogens. 121
Studio su patogeni isolati da urinocolture in un laboratorio di riferimento ligure (ottobre 2010‐marzo 2011) 119
Attività in vitro di tigeciclina su 200 ceppi (tigecycline evaluation and surveillance trial -t.e.s.t.- program) 119
Epidemiologia di Enterobacteriaceae e non fermentanti, isolati nell’area ligure. 119
In vitro susceptibility criteria for selecting empiric therapy in serious surgical infections 119
Post-antibiotic effect induced by ofloxacin in both gram-positive and gram-negative bacteria. 118
La concentrazione che previene lo sviluppo di mutanti resistenti (MPC): un nuovo parametro per la scelta tra Fluorochinoloni 118
In vitro synergism between rokitamycin and co-trimoxazole against Streptococcus pyogenes, Streptococcus pneumoniae and staphylococci. 118
Comparative evaluation of antimicrobial efficacy of sodium hypochlorite, MTAD, and Tetraclean against Enterococcus faecalis biofilm. 117
Antimicrobial profile of cefixime 117
In vitro activity of ABT773, a new ketolide derivative exhibiting innovative microbiological properties against well-characterised antibiotic resistant pathogens in Italy. 117
Comparative in vitro activity of gemifloxacin (SB-265805), a new fluoroquinolone, against respiratory tract pathogens 116
Interazione sinergica dei glicopeptidi con ceftazidime e azitromicina nei confronti di Pseudomonas aeruginosa. 116
The beta-lactamase problem: new therapeutic options. 116
Dactimicin, a new aminoglycoside: in vitro activity, post- antibiotic effect, and interaction with other antibiotics. 116
Periodontal disease and coronary heart disease: an epidemiological and microbiological study 116
Saggio di sensibilità agli antibiotici con il sistema uro-quick su patogeni isolati in reparti di terapia intensiva 115
In vitro activity of metronidazole alone and in combination with clotrimazole against clinical isolates of Trichomonas vaginalis. 115
Identificazione e resistenza agli antibiotici di ceppi ben caratterizzati analizzati in laboratori liguri 114
Molecular analysis and susceptibility patterns of meticillin-resistant Staphylococcus aureus (MRSA) strains circulating in the community in the Ligurian area, a northern region of Italy: emergence of USA300 and EMRSA-15 clones 114
Indagine sulla diffusione di Stafilococchi resistenti alla meticillina in Liguria. 114
A multicentric study of resistance to antibiotic [indagine AMCLI sulla prevalenza in un giorno indice di resistenze agli antibiotici] 113
Totale 15.579
Categoria #
all - tutte 106.822
article - articoli 57.977
book - libri 0
conference - conferenze 48.237
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 608
Totale 213.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 0 0 0 0 0 0 99
2021/20223.894 42 338 131 491 280 246 377 906 82 388 86 527
2022/20234.096 444 188 89 375 641 829 49 367 700 54 293 67
2023/20241.680 101 294 59 135 144 317 88 109 80 35 72 246
2024/20254.032 153 430 163 301 481 377 358 459 221 260 310 519
2025/20267.346 676 310 298 649 896 1.036 1.327 344 543 712 329 226
Totale 36.815